Statistical methods
The safety analysis population included all participants who received at least 1 dose of either GB1211 or placebo. No formal statistical assessment was performed for the safety analysis.The PK population comprised all participants who received at least 1 GB1211 dose and had at least one quantifiable GB1211 concentration. Dose proportionality was analyzed for exposure parameters after fasted doses. The power model was used on AUC